Inventor · disambiguated record
Zheng Li
Also filed as: LI ZHENG · LI ZHENG J · LI ZHENG JANE
24 granted patents·21 pending applications·989 citations·filing 2000–2025
96Inventor score
Files withPFIZER24UNIV CALIFORNIA53M INNOVATIVE PROPERTIES CO2ARTHROSI THERAPEUTICS INC2WARNER LAMBERT CO2
Top patents by PatentIndex Score
45 records- 0197US6486168B1Formulations and methods for treatment of mucosal associated conditions with an immune response modifier3M INNOVATIVE PROPERTIES CO·Filed 2000·Granted Nov 26, 2002·217 cites·16 claims
- 0297US6245776B1Formulations and methods for treatment of mucosal associated conditions with an immune response modifier3M INNOVATIVE PROPERTIES CO·Filed 2000·Granted Jun 12, 2001·456 cites·22 claims
- 0396US7053192B2Crystal forms of azithromycinPFIZER·Filed 2005·Granted May 30, 2006·38 cites·9 claims
- 0496US6605729B1Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)WARNER LAMBERT CO·Filed 2002·Granted Aug 12, 2003·104 cites·15 claims
- 0592US6965027B2Crystalline 3-{4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citratePFIZER·Filed 2002·Granted Nov 15, 2005·38 cites·6 claims
- 0688US7105179B2Crystal forms of azithromycinPFIZER·Filed 2005·Granted Sep 12, 2006·7 cites·13 claims
- 0788US6844349B2Salt forms of E-2-methoxy-N-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of productionPFIZER·Filed 2002·Granted Jan 18, 2005·32 cites·30 claims
- 0886US7960407B2Crystal forms of an imidazole derivativeRAQUALIA PHARMA INC·Filed 2006·Granted Jun 14, 2011·15 cites·8 claims
- 0985US6977243B2Crystal forms of azithromycinPFIZER·Filed 2002·Granted Dec 20, 2005·14 cites·19 claims
- 1084US6861413B2Stable non-dihydrate azithromycin oral suspensionsPFIZER·Filed 2003·Granted Mar 1, 2005·19 cites·4 claims
- 1182US7803805B2Cristalline 3-{(3R,4R)-4 methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile mono citrate saltPFIZER·Filed 2005·Granted Sep 28, 2010·4 cites·9 claims
- 1282US7081525B2Crystal forms of azithromycinPFIZER·Filed 2005·Granted Jul 25, 2006·3 cites·8 claims
- 1382US6734308B2Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1H-quinolin-2-one, 2,3,- dihydroxybutanedioate salts and method of productionPFIZER·Filed 2003·Granted May 11, 2004·15 cites·3 claims
- 1480US7144915B2Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)WARNER LAMBERT CO·Filed 2003·Granted Dec 5, 2006·9 cites·46 claims
- 1578US12145917B2Crystalline forms of a compound for treating or preventing gout or hyperuricemiaARTHROSI THERAPEUTICS INC·Filed 2019·Granted Nov 19, 2024·1 cites·18 claims
- 1678US7309782B2Crystal forms of azithromycinPFIZER·Filed 2003·Granted Dec 18, 2007·6 cites·20 claims
- 1775US9981961B2Deoxycytidine kinase inhibitorsUNIV CALIFORNIA·Filed 2017·Granted May 29, 2018·2 cites·23 claims
- 1875US9598404B2Deoxycytidine kinase inhibitorsUNIV CALIFORNIA·Filed 2016·Granted Mar 21, 2017·2 cites·19 claims
- 1972US6645982B2Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1H-quinolin-2-one, 2,3-dihydroxybutanedioate salts and method of productionPFIZER·Filed 2001·Granted Nov 11, 2003·5 cites·26 claims
- 2066US7282486B2Crystal forms of azithromycinPFIZER·Filed 2003·Granted Oct 16, 2007·1 cites·18 claims
- 2165US2008287521A1Crystalline Forms Of [R-(R*,R*)-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methyl- Ethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calcium Salt (2:1)PFIZER·Filed 2008·Application pending·0 cites
- 2265US2025059150A1Crystalline forms of a compound for treating or preventing gout or hyperuricemiaARTHROSI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2365US2025375405A1N-lactoyl-phenylalanine for preventing and/or treating ischemic heart disease and method for preventing and/or treating ischemic heart diseaseUNIV HARBIN MEDICAL·Filed 2024·Application pending·0 cites
- 2463US2008214651A1Crystalline forms of [R-(R*, R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)PFIZER·Filed 2007·Application pending·0 cites
- 2561US7307156B2Crystal forms of azithromycinPFIZER·Filed 2003·Granted Dec 11, 2007·1 cites·12 claims
- 2661US2025129388A1Temperature regulated crispr-cas systems and methods of use thereofUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 2761US2023303542A1Solid forms of a parp14 inhibitorRIBON THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2858US2024102032A1Crispr-cas effector polypeptides and methods of use thereofUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 2957US2023159943A1Crispr systems in plantsUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 3052US2004266832A1Crystal forms of 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl pyridineFiled 2004·Application pending·0 cites
- 3151US2025034129A1CRYSTALLINE FORMS OF (6S,7S)-6-FLUORO-7-(2-FLUORO-5-METHYLPHENYL)-3-(TETRAHYDRO-2H-PYRAN-4-YL)-5,6,7,8-TETRAHYDROPYRIDO[2,3-d]PYRIMIDINE-2,4(1H,3H)-DIONEMYOKARDIA INC·Filed 2023·Application pending·0 cites
- 3250US2005020836A1Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4(3-ethynyl-phenyl)-1methyl-1h-quinolin-2-one, 2,3,-dihydroxybutanedioate salts and method of productionPFIZER·Filed 2004·Application pending·0 cites
- 3347US6683106B2N-(indole-2-carbonyl)-b-alaninamide crystal formsPFIZER·Filed 2003·Granted Jan 27, 2004·0 cites·12 claims
- 3446US2005010374A1Method of analysis of NIR dataPFIZER·Filed 2004·Application pending·0 cites
- 3545US2004152758A1N-(indole-2-carbonyl)-b-alaninamide crystal formsPFIZER·Filed 2003·Application pending·0 cites
- 3644US2014094486A1Solid state forms of hiv inhibitorGILEAD SCIENCES INC·Filed 2013·Application pending·0 cites
- 3744US2005075354A1Complexes of E-2-Methoxy-N(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinzazolin-6-YL}-allyl)-acetamide, their method of production, and usePFIZER·Filed 2003·Application pending·0 cites
- 3843US2005192298A1Crystal forms of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamidePFIZER·Filed 2005·Application pending·0 cites
- 3943US2025255851A1Solid forms of an aldosterone synthase inhibitorBOEHRINGER INGELHEIM INT·Filed 2025·Application pending·0 cites
- 4043US2005119275A1Salt and crystal forms of (5-chloro-2-{2-[4-(4-fluoro-benzyl)-(2R,5S)-2,5-dimethyl-piperazin-1-yl]-2-oxo-ethoxy}-phenyl)-methanesulfonic acidPFIZER·Filed 2004·Application pending·0 cites
- 4142US2023017378A1Gabaa positive allosteric modulator compounds, methods of making, and uses thereofNEUROCYCLE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4242US2004072834A1Crystal forms of quinoxaline-2-carboxylic acid [4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyl-octyl]-amidePFIZER·Filed 2003·Application pending·0 cites
- 4342US2005070599A1Crystal forms of 4-[4-(4-fluorophenoxy)benzenesulfonylamino]-tetrahydropyran-4-carboxylic acid hydroxyamideFiled 2004·Application pending·0 cites
- 4440US11236081B2Crystalline salts of corydalmineYANG ZHENG·Filed 2018·Granted Feb 1, 2022·0 cites·19 claims
- 4540US6949652B2Crystalline forms of 3-isopropyl-6-[4-(2,5-difluoro-phenyl)-oxazol-5-yl]-[1,2,4]triazolo-[4,3-A]pyridinePFIZER·Filed 2003·Granted Sep 27, 2005·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Zheng Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →